Metrics as of 10/17/2026, 05:12 AM (Berlin time), refresh in progress.
Elevance Health Inc.
Elevance Health Inc., trading under the ticker symbol ELV, operates in the healthcare/medical sector within the healthcare plans industry. Founded in 1944, the U.S.-based company serves approximately 118 million people as a comprehensive healthcare provider and is headquartered in Indianapolis. Following its…
AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.
1D
-0.0%
1W
+3.8%
1M
+3.8%
6M
+32.6%
YTD
+22.2%
1Y
+23.0%
2Y
-13.8%
5Y
+9.0%
10Y
+253.7%
Next earnings date
21/10/2026 (in 4 days)
Volatility around earnings
~56% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Elevance Health Inc. is a comprehensive healthcare provider primarily operating in the health insurance sector. The company offers solutions in medical care, digital health, pharmacy, and behavioral health, serving approximately 118 million people. With a focus on the Health Benefits segment, the company generates the majority of its revenues through insurance services, while the Carelon Services segment provides specialized healthcare services. The business model is characterized by high relevance in medical care delivery and a strong market presence.
PRICE TARGET LOW
US$391.00
CONSENSUS
US$445.13
MEDIAN
US$460.00
PRICE TARGET HIGH
US$498.00
0
STRONG BUY
27
BUY
11
HOLD
0
SELL
0
STRONG SELL
38
TOTAL · Buy
As of: 12/10/2026
P/E
19.03
P/B
2.08
EV/EBITDA
13.37
RETURN ON EQUITY
3.3%
NET MARGIN
2.9%
DEBT/EQUITY
0.69
DIVIDEND YIELD
1.6%
AS OF
30/06/2026
FREE FLOAT
99.8%
FLOAT SHARES
216,372,659
AVG. DAILY VOLUME (30D)
1,276,020
Kaye Mark
Kaye Mark
Wessling Erin M
Wessling Erin M
Craig Ryan R
Price since yesterday: -0.0%
Search (Google Trends)
Register for free
Register now to see which funds are invested
Elevance Health Inc. is a company in the Healthcare sector, Medical - Healthcare Plans industry, headquartered in United States.
The CEO is Gail Koziara Boudreaux, the company employs around 96,615 people.
The IPO was on 30/10/2001; the stock trades on NYSE under the ticker ELV.
38 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$445.13, ranging from US$391.00 to US$498.00, with a median of US$460.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 21/10/2026.
Around past earnings, price swings were roughly 56% stronger than usual.
Yes. The last dividend was US$1.72 per share, ex-date 10/09/2026, paid on 25/09/2026.
The dividend yield is 1.6% (as of 30/06/2026).
Comparable stocks include UnitedHealth Group, CVS Health, Cigna, Humana, Centene, Molina Healthcare and Oscar Health.
Clicking "Analyze stock" lets five strategies assess Elevance Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.